A novel postbiotic from lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function

Frontiers in Microbiology

Volumn 10, Issue MAR, 2019, Pages

  Gao, Jie ^a   Li, Yubin ^a   Wan, Yu ^a   Hu, Tongtong ^a   Liu, Liting ^b   Yang, Shaojie ^a   Gong, Zelong ^a   Zeng, Qing ^a   Wei, Yi ^a   Yang, Weijun ^a   Zeng, Zhijie ^a   He, Xiaolong ^a   Huang, Sheng He ^a,c   Cao, Hong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b DALI UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bacterial translocation; Colitis; Intestinal barrier function; Lactobacillus rhamnosus GG; Mucin; Postbiotic; Probiotic; Tight junction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GENOMIC DNA; INTERLEUKIN 6; KI 67 ANTIGEN; MUCIN; MUCIN 2; OCCLUDIN; PECTIN; POLYHISTIDINE TAG; PROBIOTIC AGENT; PROTEIN ZO1; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN HM0539; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BODY WEIGHT CHANGE; BODY WEIGHT LOSS; CACO-2 CELL LINE; CONTROLLED STUDY; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; DNA ISOLATION; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; EXPERIMENTAL BACTERIAL INFECTION; FEMALE; HISTOPATHOLOGY; HYDROGEL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTESTINAL PROTECTION; INTESTINE FUNCTION DISORDER; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDE-INDUCED LIVER INJURY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LIVER FUNCTION TEST; MICROTITER PLATE ASSAY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; RAT; STOMACH PROTECTION; TRANSEPITHELIAL RESISTANCE; WESTERN BLOTTING;

EID: 85066506698     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2019.00477     Document Type: Article

References (65)

1. Aguilar-Toalá, J., Garcia-Varela, R., Garcia, H., Mata-Haro, V., González-Córdova, A., Vallejo-Cordoba, B., et al. (2018). Postbiotics: an evolving term within the functional foods field. Trends Food Sci. Technol. 75, 105–114. doi: 10.1016/j.tifs.2018.03.009
2. Arike, L., Holmén-Larsson, J., and Hansson, G. C. (2017). Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. Glycobiology 27, 318–328. doi: 10.1093/glycob/cww134
3. Assimakopoulos, S. F., Triantos, C., Maroulis, I., and Gogos, C. (2018). The role of the gut barrier function in health and disease. Gastroenterol. Res. 11, 261–263. doi: 10.14740/gr1053w
4. Biagioli, M., Capobianco, D., Carino, A., Marchianò, S., Fiorucci, C., Ricci, P., et al. (2018). Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties. Front. Microbiol. 9:2669. doi: 10.3390/nu11020325
5. Birchenough, G. M., Dalgakiran, F., Witcomb, L. A., Johansson, M. E., Mccarthy, A. J., Hansson, G. C., et al. (2017). Postnatal development of the small intestinal mucosa drives age-dependent, regio-selective susceptibility to Escherichia coli K1 infection. Sci. Rep. 7:83. doi: 10.1038/s41598-017-00123-w
6. Birchenough, G. M., Johansson, M. E., Stabler, R. A., Dalgakiran, F., Hansson, G. C., Wren, B. W., et al. (2013). Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic Escherichia coli. Infect. Immun. 81, 3264–3275. doi: 10.1128/IAI.00268-13
7. Brecht, M., Garg, A., Longstaff, K., Cooper, C., and Andersen, C. (2016). Lactobacillus sepsis following a laparotomy in a preterm infant: a note of caution. Neonatology 109, 186–189. doi: 10.1159/000441965
8. Bron, P. A., Kleerebezem, M., Brummer, R.-J., Cani, P. D., Mercenier, A., Macdonald, T. T., et al. (2017). Can probiotics modulate human disease by impacting intestinal barrier function? Br. J. Nutr. 117, 93–107. doi: 10.1017/S0007114516004037
9. Choksi, Y. A., Reddy, V. K., Singh, K., Barrett, C. W., Short, S. P., Parang, B., et al. (2018). BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol. 5, 1363–1374. doi: 10.1038/s41385-018-0043-2
10. Cicenia, A., Scirocco, A., Carabotti, M., Pallotta, L., Marignani, M., and Severi, C. (2014). Postbiotic activities of lactobacilli-derived factors. J. Clin. Gastroenterol. 48, S18–S22. doi: 10.1097/MCG.0000000000000231
11. Coureuil, M., Lécuyer, H., Bourdoulous, S., and Nassif, X. (2017). A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers. Nat. Rev. Microbiol. 15, 149–159. doi: 10.1038/nrmicro.2016.178
12. Croxen, M. A., and Finlay, B. B. (2010). Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8, 26–38. doi: 10.1038/nrmicro2265
13. Dani, C., Coviello, C., Corsini, I., Arena, F., Antonelli, A., and Rossolini, G. M. (2016). Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review. Am. J. Perinatol. Rep. 6, e25–e29. doi: 10.1055/s-0035-1566312
14. Deshmukh, H. S., Liu, Y., Menkiti, O. R., Mei, J., Dai, N., O’leary, C. E., et al. (2014). The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat. Med. 20, 524–530. doi: 10.1038/nm.3542
15. Donato, K. A., Gareau, M. G., Wang, Y. J. J., and Sherman, P. M. (2010). Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α-induced barrier dysfunction and proinflammatory signalling. Microbiology 156, 3288–3297. doi: 10.1099/mic.0.040139-0
16. Doron, S., and Snydman, D. R. (2015). Risk and safety of probiotics. Clin. Infect. Dis. 60, S129–S134. doi: 10.1093/cid/civ085
17. Eichele, D. D., and Kharbanda, K. K. (2017). Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J. Gastroenterol. 23, 6016–6029. doi: 10.3748/wjg.v23.i33.6016
18. Ewaschuk, J., Endersby, R., Thiel, D., Diaz, H., Backer, J., Ma, M., et al. (2007). Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46, 841–850. doi: 10.1002/hep.21750
19. FAO and WHO (2001). Health and Nutrition Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Antergia: FAO/WHO, 1–34.
20. Harb, H., Van Tol, E., Heine, H., Braaksma, M., Gross, G., Overkamp, K., et al. (2013). Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin. Exp. Allergy 43, 353–364. doi: 10.1111/cea.12047
21. He, X., Zeng, Q., Puthiyakunnon, S., Zeng, Z., Yang, W., Qiu, J., et al. (2017). Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense. Sci. Rep. 7:43305. doi: 10.1038/srep43305
22. Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., and Ross, R. P. (2018). The Lactobacillus casei group: history and health related applications. Front. Microbiol. 9:2107. doi: 10.3389/fmicb.2018.02107
23. Katayama, H., Nagasu, T., and Oda, Y. (2001). Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 15, 1416–1421. doi: 10.1002/rcm.379
24. König, J., Wells, J., Cani, P. D., García-Ródenas, C. L., Macdonald, T., Mercenier, A., et al. (2016). Human intestinal barrier function in health and disease. Clin. Transl. Gastroenterol. 7:e196. doi: 10.1038/ctg.2016.54
25. Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., et al. (2016). Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat. Commun. 7:12365. doi: 10.1038/ncomms12365
26. Koskenniemi, K., Koponen, J., Kankainen, M., Savijoki, K., Tynkkynen, S., De Vos, W. M., et al. (2009). Proteome analysis of Lactobacillus rhamnosus GG using 2-D DIGE and mass spectrometry shows differential protein production in laboratory and industrial-type growth media. J. Proteome Res. 8, 4993–5007. doi: 10.1021/pr9003823
27. Kraus, S., and Arber, N. (2009). Inflammation and colorectal cancer. Curr. Opin. Pharmacol. 9, 405–410. doi: 10.1016/j.coph.2009.06.006
28. Lebeer, S., Bron, P. A., Marco, M. L., Van Pijkeren, J.-P., Motherway, M. O. C., Hill, C., et al. (2018). Identification of probiotic effector molecules: present state and future perspectives. Curr. Opin. Biotechnol. 49, 217–223. doi: 10.1016/j.copbio.2017.10.007
29. Lopetuso, L. R., Scaldaferri, F., Bruno, G., Petito, V., Franceschi, F., and Gasbarrini, A. (2015). The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur. Rev. Med. Pharmacol. Sci. 19, 1068–1076.
30. Lv, L.-X., Hu, X.-J., Qian, G.-R., Zhang, H., Lu, H.-F., Zheng, B.-W., et al. (2014). Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats. Appl. Microbiol. Biotechnol. 98, 5619–5632. doi: 10.1007/s00253-014-5638-2
31. Mack, D. R., Michail, S., Wei, S., Mcdougall, L., and Hollingsworth, M. A. (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276, G941–G950. doi: 10.1152/ajpgi.1999.276.4.G941
32. Maloy, K. J., and Powrie, F. (2011). Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306. doi: 10.1038/nature10208
33. Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D., Hirschfield, G. M., Hold, G., et al. (2016). The gut microbiota and host health: a new clinical frontier. Gut 65, 330–339. doi: 10.1136/gutjnl-2015-309990
34. Martens, E. C., Neumann, M., and Desai, M. S. (2018). Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457–470. doi: 10.1038/s41579-018-0036-x
35. Martín, R., Laval, L., Chain, F., Miquel, S., Natividad, J., Cherbuy, C., et al. (2016). Bifidobacterium animalis ssp. lactis CNCM-I2494 restores gut barrier permeability in chronically low-grade inflamed mice. Front. Microbiol. 7:608. doi: 10.3389/fmicb.2016.00608
36. Mazmanian, S. K., Round, J. L., and Kasper, D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620–625. doi: 10.1038/nature07008
37. Morita, T., Tanabe, H., Takahashi, K., and Sugiyama, K. (2004). Ingestion of resistant starch protects endotoxin influx from the intestinal tract and reduces D-galactosamine-induced liver injury in rats. J. Gastroenterol. Hepatol. 19, 303–313. doi: 10.1111/j.1440-1746.2003.03208.x
38. Orlando, A., Linsalata, M., Notarnicola, M., Tutino, V., and Russo, F. (2014). Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol. 14:19. doi: 10.1186/1471-2180-14-19
39. Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M., Schütte, A., et al. (2014). The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol. Rev. 260, 8–20. doi: 10.1111/imr.12182
40. Peterson, L. W., and Artis, D. (2014). Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141–153. doi: 10.1038/nri3608
41. Petersson, J., Schreiber, O., Hansson, G. C., Gendler, S. J., Velcich, A., Lundberg, J. O., et al. (2010). Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am. J. Physiol. 300, G327–G333. doi: 10.1152/ajpgi.00422.2010
42. Quévrain, E., Maubert, M., Michon, C., Chain, F., Marquant, R., Tailhades, J., et al. (2016). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 65, 415–425. doi: 10.1136/gutjnl-2014-307649
43. Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., et al. (2014). Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One 9:e80169. doi: 10.1371/journal.pone.0080169
44. Sánchez, B., Schmitter, J. M., and Urdaci, M. C. (2009). Identification of novel proteins secreted by Lactobacillus rhamnosus GG grown in de Mann-Rogosa-Sharpe broth. Lett. Appl. Microbiol. 48, 618–622. doi: 10.1111/j.1472-765X.2009.02579.x
45. Sanchez, B., Urdaci, M. C., and Margolles, A. (2010). Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa–bacteria interactions. Microbiology 156, 3232–3242. doi: 10.1099/mic.0.044057-0
46. Segers, M. E., and Lebeer, S. (2014). Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. Microb. Cell Fact. 13(Suppl. 1):S7. doi: 10.1186/1475-2859-13-S1-S7
47. Sharma, D., Malik, A., Guy, C. S., Karki, R., Vogel, P., and Kanneganti, T.-D. (2018). Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis. Gastroenterology 154, 948.e8–964.e8. doi: 10.1053/j.gastro.2017.11.276
48. Sharma, G., and Im, S.-H. (2018). Probiotics as a potential immunomodulating pharmabiotics in allergic diseases: current status and future prospects. Allergy Asthma Immunol. Res. 10, 575–590. doi: 10.4168/aair.2018.10.6.575
49. Shen, X., Liu, L., Peek, R. M., Acra, S. A., Moore, D. J., Wilson, K. T., et al. (2018). Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes. Mucosal Immunol. 5, 1316–1328. doi: 10.1038/s41385-018-0034-3
50. Suez, J., and Elinav, E. (2017). The path towards microbiome-based metabolite treatment. Nat. Microbiol. 2:17075. doi: 10.1038/nmicrobiol.2017.75
51. Tsilingiri, K., and Rescigno, M. (2012). Postbiotics: what else? Benef. Microbes 4, 101–107. doi: 10.3920/BM2012.0046
52. Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799–809. doi: 10.1038/nri2653
53. Vancamelbeke, M., and Vermeire, S. (2017). The intestinal barrier: a fundamental role in health and disease. Expert Rev. Gastroenterol. Hepatol. 11, 821–834. doi: 10.1080/17474124.2017.1343143
54. Wang, L., Cao, H., Liu, L., Wang, B., Walker, W. A., Acra, S. A., et al. (2014). Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J. Biol. Chem. 29, 20234–20244. doi: 10.1074/jbc.M114.553800
55. Wang, Y., Kirpich, I., Liu, Y., Ma, Z., Barve, S., Mcclain, C. J., et al. (2011). Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. J. Pathol. 179, 2866–2875. doi: 10.1016/j.ajpath.2011.08.039
56. Wang, Y., Liu, L., Moore, D. J., Shen, X., Peek, R., Acra, S. A., et al. (2017). An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol. 10, 373–384. doi: 10.1038/mi.2016.57
57. Xiong, J., Zhou, M. F., Wang, Y. D., Chen, L. P., Xu, W. F., Wang, Y. D., et al. (2016). Protein kinase d2 protects against acute colitis induced by dextran sulfate sodium in mice. Sci. Rep. 6:34079. doi: 10.1038/srep34079
58. Yan, F., Cao, H., Cover, T. L., Washington, M. K., Shi, Y., Liu, L., et al. (2011). Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121, 2242–2253. doi: 10.1172/JCI44031
59. Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., and Polk, D. B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562–575. doi: 10.1053/j.gastro.2006.11.022
60. Yan, F., Liu, L., Dempsey, P. J., Tsai, Y.-H., Raines, E. W., Wilson, C. L., et al. (2013). A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate EGF receptor. J. Biol. Chem. 42, 30742–30751. doi: 10.1074/jbc.M113.492397
61. Yan, F., and Polk, D. B. (2012). Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes 3, 25–28. doi: 10.4161/gmic.19245
62. Yoda, K., He, F., Miyazawa, K., Hiramatsu, M., and Yan, F. (2012). Fermented milk containing Lactobacillus GG alleviated DSS-induced colitis in mice and activated epidermal growth factor receptor and Akt signaling in intestinal epithelial cells. Microb. Ecol. Health Dis. 23:18586. doi: 10.3402/mehd.v23i0.18586
63. Zawistowska-Rojek, A., and Tyski, S. (2018). Are probiotic really safe for humans? Polish J. Microbiol. 67, 251–258. doi: 10.21307/pjm-2018-044
64. Zeng, Q., He, X., Puthiyakunnon, S., Xiao, H., Gong, Z., Boddu, S., et al. (2017). Probiotic mixture golden bifido prevents neonatal Escherichia coli K1 translocation via enhancing intestinal defense. Front. Microbiol. 8:1798. doi: 10.3389/fmicb.2017.01798
65. Zuo, L., Yuan, K. T., Yu, L., Meng, Q. H., Chung, C. K., and Yang, D. H. (2014). Bifidobacterium infantis attenuates colitis by regulating t cell subset responses. World J. Gastroenterol. 20, 18316–18329. doi: 10.3748/wjg.v20.i48.18316